Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287922207> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W4287922207 endingPage "2388" @default.
- W4287922207 startingPage "2378" @default.
- W4287922207 abstract "Abstract Background Nivolumab at a dose of 480 mg every 4 weeks (Q4W) is approved for the adjuvant treatment of melanoma. However, real‐world data on this regimen are limited in this setting. Methods This retrospective observational study utilized data from the US Oncology Network iKnowMed electronic health record database and patient medical charts. Eligible patients were diagnosed with melanoma and received adjuvant nivolumab monotherapy from March to August 2018. Patients were grouped by dosing regimen: cohort 1 (C1), de novo nivolumab 480 mg Q4W; cohort 2 (C2), switched to nivolumab 480 mg Q4W after nivolumab 240 mg or 3 mg/kg every 2 weeks (Q2W); cohort 3 (C3), de novo nivolumab 3 mg/kg Q2W; or cohort 4 (C4), de novo nivolumab 240 mg Q2W. Patients were followed for up to 12 months. Duration of therapy and safety/tolerability were assessed. Results One hundred ninety‐one patients were included (C1, n = 40; C2, n = 74; C3, n = 22; C4, n = 55). Duration of therapy was relatively consistent across cohorts (median, 10.3 months; range, 8.3–10.7). Likewise, proportions of patients experiencing treatment‐related adverse events (TRAEs) were similar (range, 54.5%–60.1%), as were the most common events (fatigue, rash, diarrhea, hypothyroidism, nausea, and pruritus). However, proportions experiencing ‘significant’ TRAEs varied between cohorts. Proportions discontinuing treatment were relatively consistent across cohorts. Propensity score matching and sensitivity analyses generally supported the unadjusted findings. Conclusions Real‐world safety profiles of nivolumab 240 mg Q2W and 480 mg Q4W were similar, and both were comparable to the well‐documented safety of weight‐based dosing (3 mg/kg Q2W), further supporting their approval and use in the adjuvant setting for melanoma." @default.
- W4287922207 created "2022-07-26" @default.
- W4287922207 creator A5001550948 @default.
- W4287922207 creator A5003806043 @default.
- W4287922207 creator A5013217019 @default.
- W4287922207 creator A5020632357 @default.
- W4287922207 creator A5035574764 @default.
- W4287922207 creator A5044515899 @default.
- W4287922207 creator A5047177507 @default.
- W4287922207 creator A5075481530 @default.
- W4287922207 creator A5087752875 @default.
- W4287922207 date "2022-07-25" @default.
- W4287922207 modified "2023-10-14" @default.
- W4287922207 title "<scp>Real‐World</scp> nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma" @default.
- W4287922207 cites W2160834915 @default.
- W4287922207 cites W2183144139 @default.
- W4287922207 cites W2549481046 @default.
- W4287922207 cites W2567068937 @default.
- W4287922207 cites W2615652585 @default.
- W4287922207 cites W2743004903 @default.
- W4287922207 cites W2752227448 @default.
- W4287922207 cites W2890930659 @default.
- W4287922207 cites W2999177201 @default.
- W4287922207 cites W3181675264 @default.
- W4287922207 cites W4293241248 @default.
- W4287922207 doi "https://doi.org/10.1002/cam4.5061" @default.
- W4287922207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35880244" @default.
- W4287922207 hasPublicationYear "2022" @default.
- W4287922207 type Work @default.
- W4287922207 citedByCount "0" @default.
- W4287922207 crossrefType "journal-article" @default.
- W4287922207 hasAuthorship W4287922207A5001550948 @default.
- W4287922207 hasAuthorship W4287922207A5003806043 @default.
- W4287922207 hasAuthorship W4287922207A5013217019 @default.
- W4287922207 hasAuthorship W4287922207A5020632357 @default.
- W4287922207 hasAuthorship W4287922207A5035574764 @default.
- W4287922207 hasAuthorship W4287922207A5044515899 @default.
- W4287922207 hasAuthorship W4287922207A5047177507 @default.
- W4287922207 hasAuthorship W4287922207A5075481530 @default.
- W4287922207 hasAuthorship W4287922207A5087752875 @default.
- W4287922207 hasBestOaLocation W42879222072 @default.
- W4287922207 hasConcept C121608353 @default.
- W4287922207 hasConcept C126322002 @default.
- W4287922207 hasConcept C143998085 @default.
- W4287922207 hasConcept C167135981 @default.
- W4287922207 hasConcept C17923572 @default.
- W4287922207 hasConcept C197934379 @default.
- W4287922207 hasConcept C2777288759 @default.
- W4287922207 hasConcept C2777701055 @default.
- W4287922207 hasConcept C2777982462 @default.
- W4287922207 hasConcept C2778375690 @default.
- W4287922207 hasConcept C2778570526 @default.
- W4287922207 hasConcept C2780030458 @default.
- W4287922207 hasConcept C2780580376 @default.
- W4287922207 hasConcept C2781413609 @default.
- W4287922207 hasConcept C71924100 @default.
- W4287922207 hasConcept C72563966 @default.
- W4287922207 hasConceptScore W4287922207C121608353 @default.
- W4287922207 hasConceptScore W4287922207C126322002 @default.
- W4287922207 hasConceptScore W4287922207C143998085 @default.
- W4287922207 hasConceptScore W4287922207C167135981 @default.
- W4287922207 hasConceptScore W4287922207C17923572 @default.
- W4287922207 hasConceptScore W4287922207C197934379 @default.
- W4287922207 hasConceptScore W4287922207C2777288759 @default.
- W4287922207 hasConceptScore W4287922207C2777701055 @default.
- W4287922207 hasConceptScore W4287922207C2777982462 @default.
- W4287922207 hasConceptScore W4287922207C2778375690 @default.
- W4287922207 hasConceptScore W4287922207C2778570526 @default.
- W4287922207 hasConceptScore W4287922207C2780030458 @default.
- W4287922207 hasConceptScore W4287922207C2780580376 @default.
- W4287922207 hasConceptScore W4287922207C2781413609 @default.
- W4287922207 hasConceptScore W4287922207C71924100 @default.
- W4287922207 hasConceptScore W4287922207C72563966 @default.
- W4287922207 hasFunder F4320307115 @default.
- W4287922207 hasIssue "3" @default.
- W4287922207 hasLocation W42879222071 @default.
- W4287922207 hasLocation W42879222072 @default.
- W4287922207 hasLocation W42879222073 @default.
- W4287922207 hasOpenAccess W4287922207 @default.
- W4287922207 hasPrimaryLocation W42879222071 @default.
- W4287922207 hasRelatedWork W2800160190 @default.
- W4287922207 hasRelatedWork W2890849069 @default.
- W4287922207 hasRelatedWork W2898986397 @default.
- W4287922207 hasRelatedWork W2916985439 @default.
- W4287922207 hasRelatedWork W2976744492 @default.
- W4287922207 hasRelatedWork W2981652925 @default.
- W4287922207 hasRelatedWork W2989731915 @default.
- W4287922207 hasRelatedWork W3021851930 @default.
- W4287922207 hasRelatedWork W4206636567 @default.
- W4287922207 hasRelatedWork W4221108986 @default.
- W4287922207 hasVolume "12" @default.
- W4287922207 isParatext "false" @default.
- W4287922207 isRetracted "false" @default.
- W4287922207 workType "article" @default.